Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Nov 04, 2021 9:50 AM - Nov 05, 2021 5:00 PM

(US Eastern Standard Time)

Master Protocols and Complex Innovative Design

Innovating for Modernized Clinical Trials

Session 3: The Art of Implementing and Conducting Platform Trials

Session Chair(s)

Michelle A Detry, PHD

Michelle A Detry, PHD

Director, Adaptive Trial Execution & Senior Statistical Scientist, Berry Consultants, LLC, United States

Anne-Marie  Duliege

Anne-Marie Duliege

Chief Medical Officer, Pancreatic Cancer Action Network, United States

This session will present the main strategic and operational considerations during the preparation and implementation of platform trials. Platform trials require an intense collaboration among numerous groups that differs from the standard clinical trial infrastructure. Their viewpoints must be integrated to meet the common goal of the platform. The speakers will describe their roles in the design and conduct of various ongoing platform trials, as well as some of the challenges they may face.

Learning Objective :
  • Understand the role of the various partners required to conduct a platform trial, and their contributions to the value of this trial
  • Identify the unique perspectives and operational challenges involved in conducting a platform trial
  • Understand the importance of an intense collaboration between the partners to address these challenges and contribute to an optimal conduct of a platform trial

Speaker(s)

Meredith  Buxton, PHD, MPH

Meredith Buxton, PHD, MPH

Chief Executive Officer, Global Coalition For Adaptive Research, United States

Identifying the Right Industry Partners: The Role of the Sponsor

Vincent  Picozzi

Vincent Picozzi

, Virginia Mason Franciscan Health, United States

Advancing the Science: The Perspective of an Investigator

Ewa  Carrier, DrMed

Ewa Carrier, DrMed

Executive Director, Fibrogen, United States

Advancing the Science: Joining a Platform Trial: the Perspective of the Biopharma Partner

Len  Rosenberg, PHD, RPH

Len Rosenberg, PHD, RPH

, United States

Operational Excellence: The Ultimate Collaboration Between the Sponsor and the CRO

Melanie  Quintana, PHD

Melanie Quintana, PHD

Director & Senior Statistical Scientist, Berry Consultants, LLC, United States

The Critical Role of the Blinded Statistician: Role and Interactions with the FDA

Sabrina  Paganoni, MD, PHD

Sabrina Paganoni, MD, PHD

Assistant Professor, Harvard Medical School, Healey Center for ALS at Mass General, United States

Patients as Research Partners

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.